Italian reimbursement system for medical devices and IVD tests
This online on-demand 30-minute seminar gives a comprehensive understanding of the hospital reimbursement landscape for medical devices in Italy. Additional modules cover reimbursement of IVD tests and screening methods
Available as pre-recorded webinar or full presentation in Acrobat PDF
Italy is one of the biggest medical device markets in Europe. However, market access is very complicated in this country.
At the hospital level, funding is performed using a global budget or diagnosis-related groups. As no changes in the DRG system are possible at the national level, regions should work on the implementation of reimbursement changes (e.g., DRG split or add-on reimbursement). Lack of structured processes and need to address regions individually makes market access processes very complex and lengthy.
Another aspect of market access in Italy is acceptance by payors. Italy has a very diverse and complex decision-making structure, including national, regional and hospital-based health technology assessment organizations and Technical Committees for medical devices. Obtaining endorsement from these stakeholders is another essential element of market access strategy in Italy.
Our seminar can help you to navigate the hospital-based reimbursement environment for medical devices in Italy.
What topics are reviewed?
Key stakeholders and their role in reimbursement processes
Key stakeholders are reviewed, including payers (ASLs), policy-makers (Ministry of Health, regions, Steering Committee for HTA), advising organizations (HTA and Technical Commissions for Medical Devices)
Nationally guaranteed services
The concept of Essential Levels of Care (LEA), update of LEA catalogue, process and stakeholders involved is reviewed
Payment model
Payment model in hospital sector (global budget and DRG), specifics of DRG system, activity of regions in relation to amendments of DRG system (DRG split and add-on reimbursement)
Decision-making framework and role of HTA
Health technology assessment stakeholders and processes, role of HTA in adoption of medical technologies, brief overview of the emerging national process for HTA
Additional modules
Reimbursement system for in-vitro diagnostic tests
A separate comprehensive overview of the reimbursement system for IVD tests in Italy
Organization and financing of screening methods
A separate comprehensive overview of the organizational and financing framework of screening methods (e.g. breast and cervical cancer screening) in Italy
What topics are not covered?
Some topics are not specifically covered in this seminar: reimbursement model in out-patient settings, reimbursement for medical aids (devices for home use), funding of capital equipment.
The introductory presentation also does not include details of reimbursement application processes (for example application form, requirements, details of the process for HTA processes nationally and regionally).
Topics that are not covered in this seminar will be included in future courses. You can subscribe to our newsletter and inform us about your particular interests at the main page of the Market Access Academy.
How is the seminar delivered?
Option #1: Pre-recorded webinar
One option is to watch the seminar, which is provided as a pre-recorded webinar. The duration of the webinar is 30 minutes. Seminar is available for 6 months
Option #2: Presentation in Acrobat PDF
You can also access just the educational material - the full presentation of the seminar in Acrobat PDF
View extract from the seminar
This 2-minute extract presents overview of the diagnosis-related group (DRG) system in Italy
Request a quote
Click the button below to request a quote for the seminar
